Meridian Bioscience Revenue and Competitors

Location

#4568

Growjo Ranking

Estimated Revenue & Valuation

  • Meridian Bioscience's estimated annual revenue is currently $317.9M per year.(i)
  • Meridian Bioscience received $58.0M in venture funding in September 2005.
  • Meridian Bioscience's estimated revenue per employee is $494,401
  • Meridian Bioscience's current valuation is $905.9M. (January 2022)

Employee Data

  • Meridian Bioscience has 643 Employees.(i)
  • Meridian Bioscience grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$464.4M185024%N/AN/A
#2
$16.6M6618%N/AN/A
#3
$7.8M310%N/AN/A
#4
$3.8M150%N/AN/A
#5
$19.1M763%N/AN/A
#6
$70M2798%N/AN/A
#7
$4.5M18-14%N/AN/A
#8
$135.3M5390%N/AN/A
#9
$10M40-9%N/AN/A
#10
$8M3223%N/AN/A
Add Company

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, rare reagents, specialty biologicals and components. Utilizing a variety of methods, our diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as infections and lead poisoning. Meridian's diagnostic products are used outside of the human body and require little or no special equipment. The Company's diagnostic products are designed to enhance patient well-being while reducing the total outcome costs of health care. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, and blood lead level testing. In addition, Meridian is a supplier of rare reagents, specialty biologicals and components used by organizations in the life science and agri-bio industries engaged in research. Many companies also utilize Meridian's products as components in the manufacture of diagnostics. The Company markets its products and technologies to hospitals, reference laboratories, research centers, diagnostics manufacturers, and agri-bio companies in more than 70 countries around the world. The Company's shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.

keywords:Biotechnology,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals

N/A

Total Funding

643

Number of Employees

$317.9M

Revenue (est)

3%

Employee Growth %

$905.9M

Valuation

N/A

Accelerator

Meridian Bioscience News

2022-04-17 - Analysts' Recent Ratings Updates for Meridian Bioscience ...

Meridian Bioscience, Inc, a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for...

2022-04-06 - Meridian Bioscience Announces Preliminary Net Revenues ...

About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad...

2022-03-30 - Meridian Bioscience Launches Lyo-Ready™ qPCR Inhibitor ...

About Meridian Bioscience, Inc. Meridian is a fully integrated life science company that develops, manufactures, markets, and distributes a...

2021-11-24 - Meridian Bioscience Announces Retirement of Chairman David Phillips

CINCINNATI, Nov. 24, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today that David Phillips, Chairman of the Board of Directors, will retire from the Board of Directors and not s ...

2021-11-17 - Meridian Launches Two New Air-Dryable™ Mixes for Isothermal Amplification, Powering Shortest Time-to-results in Point-of-care Testing

CINCINNATI, Nov. 17, 2021 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today the launch of its Air-Dryable™ LAMP Mix and Air-Dryable™ RT-LAMP 1-Step Mix. These ground-breaking molecul ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$165.3M6453%N/A
#2
$219.4M650N/AN/A
#3
$7.5M6638%N/A
#4
$135M67516%N/A
#5
$172.7M6886%N/A

Meridian Bioscience Funding

DateAmountRoundLead InvestorsReference
2005-09-19$58.0MUndisclosedRobert W Baird and CoArticle